Net Income Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Kunming Longjin Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was -70.94 Million CNY , up 3.52% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q3 was -5.1 Million CNY , down -2006.82% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported an annual net income of -73.52 Million CNY in 2022, down -885.61% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported an annual net income of -7.46 Million CNY in 2021, down -196.21% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported a quarterly net income of 267.77 Thousand CNY for 2024 Q2, up 105.96% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported a quarterly net income of -4.49 Million CNY for 2024 Q1, up 89.86% from previous quarter.

Annual Net Income Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Net Income	Net Income Growth
2023	-70.94 Million CNY	3.52%
2022	-73.52 Million CNY	-885.61%
2021	-7.46 Million CNY	-196.21%
2020	7.75 Million CNY	132.39%
2019	-23.93 Million CNY	-272.58%
2018	13.87 Million CNY	-60.55%
2017	35.15 Million CNY	-61.38%
2016	91.03 Million CNY	47.3%
2015	61.8 Million CNY	-2.79%
2014	63.57 Million CNY	-15.3%
2013	75.05 Million CNY	-25.09%
2012	100.2 Million CNY	43.84%
2011	69.66 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q3	-5.1 Million CNY	-2006.82%
2024 Q2	267.77 Thousand CNY	105.96%
2024 Q1	-4.49 Million CNY	89.86%
2023 Q2	-7.66 Million CNY	18.63%
2023 FY	-70.94 Million CNY	3.52%
2023 Q4	-44.29 Million CNY	-307.73%
2023 Q3	-10.86 Million CNY	-41.83%
2023 Q1	-9.41 Million CNY	85.54%
2022 Q2	-5.16 Million CNY	-720.74%
2022 Q4	-65.08 Million CNY	-1542.73%
2022 Q1	832.28 Thousand CNY	123.92%
2022 FY	-73.52 Million CNY	-885.61%
2022 Q3	-3.96 Million CNY	23.31%
2021 Q4	-3.47 Million CNY	-304.69%
2021 Q1	2.63 Million CNY	-72.33%
2021 Q2	2.23 Million CNY	-15.15%
2021 Q3	1.69 Million CNY	-24.01%
2021 FY	-7.46 Million CNY	-196.21%
2020 FY	7.75 Million CNY	132.39%
2020 Q3	3.89 Million CNY	50.66%
2020 Q2	2.58 Million CNY	161.65%
2020 Q1	-4.18 Million CNY	83.01%
2020 Q4	9.52 Million CNY	144.83%
2019 Q2	-3.89 Million CNY	-174.41%
2019 Q1	5.23 Million CNY	901.21%
2019 Q4	-24.65 Million CNY	-11893.71%
2019 FY	-23.93 Million CNY	-272.58%
2019 Q3	209.06 Thousand CNY	105.36%
2018 FY	13.87 Million CNY	-60.55%
2018 Q4	-653.67 Thousand CNY	-118.15%
2018 Q3	3.6 Million CNY	-2.15%
2018 Q2	3.68 Million CNY	-49.18%
2018 Q1	7.24 Million CNY	62.74%
2017 Q3	7.3 Million CNY	-22.71%
2017 Q4	4.45 Million CNY	-39.1%
2017 Q2	9.45 Million CNY	-32.21%
2017 Q1	13.94 Million CNY	-20.43%
2017 FY	35.15 Million CNY	-61.38%
2016 Q4	17.52 Million CNY	-55.85%
2016 Q3	39.69 Million CNY	123.04%
2016 Q2	17.79 Million CNY	11.17%
2016 Q1	16 Million CNY	-9.98%
2016 FY	91.03 Million CNY	47.3%
2015 Q4	17.78 Million CNY	19.02%
2015 Q2	14.36 Million CNY	-2.27%
2015 Q3	14.94 Million CNY	3.99%
2015 FY	61.8 Million CNY	-2.79%
2015 Q1	14.7 Million CNY	-27.62%
2014 Q1	11 Million CNY	0.0%
2014 Q2	15.52 Million CNY	41.05%
2014 Q3	16.72 Million CNY	7.69%
2014 Q4	20.31 Million CNY	21.47%
2014 FY	63.57 Million CNY	-15.3%
2013 FY	75.05 Million CNY	-25.09%
2012 FY	100.2 Million CNY	43.84%
2011 FY	69.66 Million CNY	0.0%

Peer Net Income Comparison of Kunming Longjin Pharmaceutical Co., Ltd.

Name	Net Income	Net Income Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-1.68 Billion CNY	95.802%
Anhui Fengyuan Pharmaceutical Co., Ltd.	159.28 Million CNY	144.537%
Dong-E-E-Jiao Co.,Ltd.	1.15 Billion CNY	106.164%
Livzon Pharmaceutical Group Inc.	1.95 Billion CNY	103.631%
Hainan Haiyao Co., Ltd.	-106.48 Million CNY	33.381%
Tus-Pharmaceutical Group Co., Ltd.	25.24 Million CNY	380.992%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.45 Billion CNY	104.859%
Changchun High-Tech Industries (Group) Inc.	4.53 Billion CNY	101.565%
Apeloa Pharmaceutical Co.,Ltd	1.05 Billion CNY	106.722%
PKU HealthCare Corp.,Ltd.	44.35 Million CNY	259.934%
Chengdu Huasun Technology Group Inc., Ltd.	27.65 Million CNY	356.482%
Dezhan Healthcare Company Limited	83.31 Million CNY	185.149%
Jinling Pharmaceutical Company Limited	99.65 Million CNY	171.189%
Jiuzhitang Co., Ltd.	297.41 Million CNY	123.853%
Huapont Life Sciences Co., Ltd.	302.12 Million CNY	123.481%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	618.89 Million CNY	111.463%
Shandong Wohua Pharmaceutical Co., Ltd.	58.76 Million CNY	220.716%
Hengkang Medical Group Co., Ltd.	30.77 Million CNY	330.505%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	263.27 Million CNY	126.946%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-12.31 Million CNY	-476.171%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	-783.25 Million CNY	90.943%
Jinhe Biotechnology CO., LTD.	86.45 Million CNY	182.054%
Teyi Pharmaceutical Group Co.,Ltd	253.17 Million CNY	128.021%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-148.52 Million CNY	52.238%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.04 Billion CNY	106.79%
Anhui Huangshan Capsule Co., Ltd.	64.86 Million CNY	209.37%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	110.43 Million CNY	164.24%
Zhuhai Rundu Pharmaceutical Co., Ltd.	66.89 Million CNY	206.043%
Huaren Pharmaceutical Co., Ltd.	188.06 Million CNY	137.722%
Tianjin Ringpu Bio-Technology Co.,Ltd.	452.94 Million CNY	115.662%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-43.98 Million CNY	-61.289%
Fuan Pharmaceutical (Group) Co., Ltd.	231.86 Million CNY	130.595%
Hybio Pharmaceutical Co., Ltd.	-513.87 Million CNY	86.195%
Baotou Dongbao Bio-Tech Co.,Ltd	119.88 Million CNY	159.174%
Hunan Er-Kang Pharmaceutical Co., Ltd	-195.32 Million CNY	63.68%
Changjiang Pharmaceutical Group Co., Ltd.	-605.65 Million CNY	88.287%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	192.34 Million CNY	136.882%
Fujian Cosunter Pharmaceutical Co., Ltd.	-348.58 Million CNY	79.649%
Beijing Science Sun Pharmaceutical Co., Ltd.	102.91 Million CNY	168.93%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	64.35 Million CNY	210.232%
Hainan Poly Pharm. Co., Ltd	85.92 Million CNY	182.564%
Jiangxi Synergy Pharmaceutical Co., Ltd.	105.98 Million CNY	166.936%
Wuhan Hiteck Biological Pharma Co.,Ltd	-120.82 Million CNY	41.285%
Shandong Xinhua Pharmaceutical Company Limited	496.51 Million CNY	114.288%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	27.35 Million CNY	359.296%
PharmaBlock Sciences (Nanjing), Inc.	197.36 Million CNY	135.945%
Jinghua Pharmaceutical Group Co., Ltd.	247.69 Million CNY	128.64%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-420.05 Million CNY	83.111%
Betta Pharmaceuticals Co., Ltd.	348.03 Million CNY	120.384%
Tibet AIM Pharm. Inc.	15.38 Million CNY	561.064%
Shenzhen Kangtai Biological Products Co., Ltd.	861.3 Million CNY	108.237%
Shandong Shanda Wit Science and Technology Co., Ltd.	585.26 Million CNY	112.121%
Pacific Shuanglin Bio-pharmacy Co., LTD	612.11 Million CNY	111.59%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	138.37 Million CNY	151.269%
Xiamen Kingdomway Group Company	276.71 Million CNY	125.637%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	25.19 Million CNY	381.563%
Walvax Biotechnology Co., Ltd.	419.39 Million CNY	116.915%
Sunflower Pharmaceutical Group Co.,Ltd	1.11 Billion CNY	106.339%
Harbin Gloria Pharmaceuticals Co., Ltd	120.33 Million CNY	158.954%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	2.85 Billion CNY	102.487%
Hunan Hansen Pharmaceutical Co., Ltd.	205.01 Million CNY	134.603%
Changzhou Qianhong Biopharma CO.,LTD	181.86 Million CNY	139.009%
Shenzhen Weiguang Biological Products Co., Ltd.	218.65 Million CNY	132.445%
Honz Pharmaceutical Co., Ltd.	11.52 Million CNY	715.284%
Northeast Pharmaceutical Group Co., Ltd.	358.45 Million CNY	119.791%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	43.93 Million CNY	261.474%
Guizhou Xinbang Pharmaceutical Co., Ltd.	287.23 Million CNY	124.698%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	361.82 Million CNY	119.606%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-11.87 Million CNY	-497.303%
Zhejiang NHU Company Ltd.	2.7 Billion CNY	102.623%
ApicHope Pharmaceutical Co., Ltd	184.61 Million CNY	138.427%
Shanghai Kaibao Pharmaceutical CO.,Ltd	327.87 Million CNY	121.637%
Beijing SL Pharmaceutical Co., Ltd.	416.69 Million CNY	117.025%
Yunnan Baiyao Group Co.,Ltd	4.09 Billion CNY	101.733%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	61.64 Million CNY	215.076%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	161.53 Million CNY	143.917%
Guangdong Lifestrong Pharmacy Co., Ltd.	33.5 Million CNY	311.755%
Huadong Medicine Co., Ltd	2.83 Billion CNY	102.499%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.03 Billion CNY	106.842%
Harbin Medisan Pharmaceutical Co., Ltd.	73.66 Million CNY	196.305%
LanZhou Foci Pharmaceutical Co.,Ltd.	67.18 Million CNY	205.584%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	506.63 Million CNY	114.003%
Beijing Beilu Pharmaceutical Co., Ltd	-71.75 Million CNY	1.137%
Nanjing Hicin Pharmaceutical Co., Ltd.	36.31 Million CNY	295.347%
Renhe Pharmacy Co., Ltd.	567.25 Million CNY	112.506%
Chongqing Pharscin Pharmaceutical Co., Ltd.	32.69 Million CNY	316.952%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	563.08 Million CNY	112.599%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-661.13 Million CNY	89.27%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-414.51 Million CNY	82.886%

Global Stocks Search

Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)

Net Income Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Annual Net Income Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Net Income Comparison of Kunming Longjin Pharmaceutical Co., Ltd.